Table 4.
Laboratory results of the included COVID-19 patients after two sequential negative nucleic acid testing with repeated analyses after over 1 week
| Total | moderate | Mild | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | After negative | 1 week after negative | P | N | After negative | 1 week after negative | P | N | After negative | 1 week after negative | P | |
| WBC count, ×109 /L | 15 | 4.88 (4.16, 8.42) | 6.69 (4.6, 7.33) | 0.496 | 10 | 8.05 (4.84, 10.2) | 7.20 (4.60, 7.97) | 0.059 | 5 | 4.94 (4.07, 5.36) | 4.78 (4.22, 6.75) | 0.443 |
| Neutrophile granulocyte, % | 14 | 60.1 (46.4, 65.6) | 57.2 (49.2, 61.7) | 0.802 | 10 | 61.3 (56.8, 69.5) | 58.1 (51.6, 65.9) | 0.114 | 4 | 50.2 (47.5, 58.8) | 51.9 (47.1, 58.9) | 0.844 |
| Lymphocyte count, ×109 /L | 12 | 1.95 (1.42, 2.68) | 1.91 (1.38, 2.5) | 0.610 | 8 | 1.85 (1.42, 2.68) | 2.18 (1.24, 2.71) | 0.889 | 4 | 2.07 (1.43, 2.69) | 1.68 (1.52, 2.15) | 0.715 |
| Lymphocyte, % | 15 | 30.8 (27.1, 43.4) | 30.4 (24.1, 38) | 0.363 | 10 | 30 (22.1, 32.1) | 28.8 (21.8, 35.6) | 0.721 | 5 | 45.6 (35.4, 50) | 33.7 (28.2, 39.3) | 0.080 |
| C-reactive protein, mg/L | 12 | 1.23 (0.21, 3.11) | 0.43 (0.24, 1.39) | 0.131 | 8 | 2.14 (0.72, 19.59) | 0.86 (0.38, 2.55) | 0.128 | 4 | 0.16 (0.04, 0.99) | 0.28 (0.11, 0.47) | 1.000 |